bluebird bio, Inc.

Ownership Transactions Reported by 27 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	5	-60.4 K	100%	$2.29	-$138 K
Net	-5	-60.4 K	-100%		-$138 K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Nick Leschly	Director	$657 K			Jun 16, 2023
Andrew Obenshain	President and CEO, Director	$428 K	-$78 K	-15.4%	Mar 1, 2024
Jason Cole	Chief Strategy & Financial Off	$271 K			Aug 19, 2022
Richard A. Colvin	Chief Medical Officer	$181 K	-$18.2 K	-9.13%	Mar 1, 2024
Gina Consylman	Chief Financial Officer	$179 K			Feb 1, 2022
Thomas J. Klima	Chief Commercial & Operating Officer	$118 K	-$16.7 K	-12.4%	Jun 3, 2024
Jessica Whitten	Chief Accounting Officer	$81.4 K			Feb 1, 2022
Christopher Krawtschuk	Chief Financial Officer	$65 K	-$20.4 K	-23.9%	Mar 1, 2024
Anne-Virginie Eggimann	Chief Regulatory Officer	$60.4 K			Jul 12, 2022
Philip D. Gregory	Chief Scientific Officer	$48.8 K			Nov 11, 2021
Joseph Vittiglio	Chief Business & Legal Officer	$40.4 K	-$4.71 K	-10.4%	Mar 1, 2024
John O. Agwunobi	Director	$37.8 K			Jun 16, 2023
Mark Vachon	Director	$35.8 K			Jun 16, 2023
Najoh Tita-Reid	Director	$33.2 K			Jun 16, 2023
William D. Baird III	Chief Financial Officer	$32.6 K			Nov 11, 2021
Elisabeth Leiderman	Director	$31.8 K			Jun 16, 2023
Charlotte Jones-Burton	Director	$26.5 K			Jun 16, 2023
Wendy L. Dixon	Director	$17 K			Nov 11, 2021
Daniel Lynch	Director	$11.4 K			Nov 11, 2021
Richard Paulson	Director	$6.67 K			Apr 3, 2023
William R. Sellers	Director	$5.15 K			Nov 11, 2021
Denice Torres	Director	$3.9 K			Nov 11, 2021
Ramy Ibrahim	Director				Nov 11, 2021
O. James Sterling	Chief Financial Officer				Jul 1, 2024
Michael Cloonan	Director				Jun 20, 2024
Marcela V. Maus	Director				Nov 11, 2021
Sarah JS Glickman	Director				Nov 11, 2021

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership